Latest Shareholder Dilution News

Adherium Limited has obtained a USD 1.65 million short-term unsecured loan from its major shareholder, Trudell Medical, to fund immediate working capital needs while pursuing capital structure adjustments.

Sunstone Metals has raised $10 million through a discounted share placement, with strategic investor DGR Global acquiring a 10% stake and board representation. The funds will boost exploration and development at Sunstone’s high-potential gold-copper projects in Ecuador.

Vault Minerals has fully settled its remaining gold hedge positions, paying $31.2 million from cash reserves with no shareholder dilution. This move leaves the company entirely unhedged, maximizing its exposure to current gold prices.

Nexsen has locked in over $1.5 million in non-dilutive funding through a national research partnership, accelerating manufacturing scale-up and platform optimisation for its rapid diagnostics technology.

Constellation Resources is raising $3.22 million through a non-renounceable entitlement offer priced at $0.12 per share, aiming to bolster exploration in Western Australia and support general working capital.

Australian Oil Company Limited has closed its Share Purchase Plan, raising $155,000 by issuing over 54 million shares at $0.0029 each, to support ongoing exploration in Queensland’s Surat Basin.

Galilee Energy has finished construction of the Zydeco-1 drilling site in Louisiana, setting the stage for drilling to commence in early July 2026. The well targets a substantial 13.7 billion cubic feet of gas and 610,000 barrels of condensate, underpinning the company’s US Gulf Coast growth ambitions.

Tungsten Mining NL's Watershed Preliminary Economic Evaluation reveals a robust project with a pre-tax NPV of A$1.3 billion and a swift payback, aiming for first production by 2027 amid tightening global tungsten supply.

International Graphite Ltd (ASX:IG6) has partnered with Alkeemia S.p.A. to establish a graphite processing facility in Italy, aiming for first production in the second half of 2027 and a final investment decision by Q3 2026.

Racura Oncology has raised $34.3 million through shareholder-backed initiatives, securing funding for its lead asset RC220’s clinical trials in AML, EGFRm lung cancer, and cardioprotection in solid tumour patients.

Caravel Minerals secures an additional $15 million royalty funding from Regal Resources, doubling the funder's investment to $30 million and extending an existing loan facility to 2028.

Thor Energy’s latest soil air geochemistry survey at its HY-Range Project in South Australia has recorded natural hydrogen concentrations up to 3%, far surpassing previous readings and validating key exploration areas ahead of a major seismic survey.